Conceive is a technology company.
Conceive has raised $5.0M across 2 funding rounds.
Conceive has raised $5.0M in total across 2 funding rounds.
Conceive has raised $5.0M in total across 2 funding rounds.
Conceive's investors include Banyan Ventures, CFV Ventures, Crosslink Capital, Jenny Fielding, Scott Hartley, Everywhere Ventures (The Fund), Founder Collective, Gradient Ventures, John Lyman, Parade Ventures, Rob May, Andreessen Horowitz.
Conceive is a digital health platform specializing in fertility and pregnancy support, offering 24/7 text messaging with fertility nurses, peer coaching, evidence-based education, and cohort-based communities to help users conceive faster, reduce costs, and uncover diagnoses.[1][2][3][6] It serves individuals and couples navigating fertility challenges, including IVF, through personalized programs like an 8-week cohort costing $549, with reported outcomes including 54-61% pregnancy rates within months and 76% improved feelings of support.[3][6] Named a Challenger in the virtual & hybrid fertility clinics market alongside Maven and Progyny, Conceive operates remotely from New York, focusing on outcomes-oriented care that complements clinic treatments.[1][2]
Founded in 2021 by Lauren Berson, a tech executive from WW (formerly Weight Watchers), Omada Health, and MasterClass, along with health providers from Cornell and CCRM, Conceive emerged to address gaps in fertility support.[2][3][4] The idea stemmed from Berson's vision for an integrated digital solution combining community, education, and coaching, launched via public beta in April 2022 after raising $3.7M in seed funding led by Kindred Ventures, with participation from Founder Collective, Great Oaks, and angels like founders of Natalist and Tia.[2][3] Early traction was strong: private beta saw 54% pregnancies, 36% new diagnoses, and 90% feeling supported, fueling expansion plans into male fertility, LGBTQ+ support, egg freezing, and post-loss conception.[3]
Conceive rides the digital health wave in virtual & hybrid fertility clinics, driven by rising infertility awareness, telehealth adoption post-COVID, and demand for at-home/remote solutions like testing kits and apps (e.g., competitors Oova, Flo Health).[1] Timing aligns with market growth in reproductive tech, where tech-enabled services address clinic backlogs and high costs, positioning Conceive as a complement to in-person care like Kindbody.[1][2] It influences the ecosystem by pioneering outcomes-based models, diverse cap tables (42% BIPOC, majority female), and remote operations, accelerating accessible fertility support amid aging populations and delayed parenthood trends.[2][3]
Conceive's momentum—strong beta results, seed funding, and product expansions—positions it to scale memberships like Plus and Premium amid booming digital fertility demand.[2][3][6] Trends like AI personalization, male/LGBTQ+ inclusivity, and hybrid clinic integrations will shape its path, potentially capturing share from Progyny-like players. Its influence may evolve into a full reproductive health leader, uncovering more diagnoses and cutting costs, ultimately helping more users navigate the fertility maze with confidence.
Conceive has raised $5.0M across 2 funding rounds. Most recently, it raised $1.0M Seed in August 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2024 | $1.0M Seed | Banyan Ventures, CFV Ventures, Crosslink Capital, Jenny Fielding, Scott Hartley, Everywhere Ventures (The Fund), Founder Collective, Gradient Ventures, John Lyman, Parade Ventures, Rob May | |
| Apr 1, 2022 | $4.0M Seed | Andreessen Horowitz, Cake Ventures, Coelius Capital, Founder Collective, Kindred Ventures, Stellar Capital |